Skip to main content
. Author manuscript; available in PMC: 2014 Jul 2.
Published in final edited form as: J Pharmacol Exp Ther. 2005 Sep 6;315(3):1320–1330. doi: 10.1124/jpet.105.090423

Table 1.

Potency estimates and comparisons for buprenorphine and methadone across behavioral measures.

Buprenorphine
ED50, mg, i.v. (±95% C.L.)
Methadone
ED50, mg, i.v. (±95% C.L.)
Potency Ratio
(±95% C.L.)
Progressive Ratio
Progressive Ratio 1.5 (0.0090-7.5) 8.7 (5.5-20) 5.0 (3.1-8.0)
Visual Analog Scale
Pay 4.1 (0.070-6.9) 17 (5.0-18) 12 (6.1-20)
Good 5.8 (4.3-8.6) 14 (9.7-23) 8.5 (7.3-9.6)
High 7.4 (0.25-5.8) 16 (13-23) 8.7 (6.4-11)
Liked 4.9 (3.4-7.2) 14 (9.5-26) 8.8 (7.6-10)
Quality 8.6 (0.63-5.9) 16 (5.4-17) 4.5 (1.2-18)
Potent 7.6a 17 (5.4-17) 4.6 (0.32-55)
Drug Effects Questionnaire
Good Effects 1.2 (0.65-6.4) 8.5 (5.7-12) 5.5 (1.9-15)
Like 0.98 (0.65-7.7) 6.1 (2.3-23) 4.4 (1.6-12)
Take Again 1.1 (0.65-6.4) 7.8 (5.8-21) 5.3 (1.6-17)
Strength 1.2 (0.73-19) 7.9 (5.7-18) 5.0 (2.2-11)
Physiological Effects
Tracking 0.94 (0.78-8.7) 20 (5.6-17) 28 (6.2-131)
Maximum Speed 0.27 (0.67-6.3) 14 (5.6-18) 51 (1.7-1500)
False Alarms 2.4 (0.64-6.2) 14 (5.7-19) 5.8a
a

Confidence limits could not be determined for the value